v3.26.1
10-K Basis of presentation and consolidation (Tables)
3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of investments in and advances to affiliates
The following table presents the wholly-owned subsidiaries of the Company as well as the entities in which the Company held a controlling financial interest as of December 31, 2025 and 2024:
As of December 31,
2025
2024
Entity name
Jurisdiction of Incorporation/Formation
Ownership %(1)
Curaleaf International Holdings Limited
Guernsey
100%
68.5%
Curaleaf, Inc.*
DE
Northern Green Canada Inc.
Canada
100%
100%
Bloom Fungibles, LLC
AZ
100%
100%
Focused Employer, Inc.
DE
100%
100%
(1) Based on % of voting interests held by the Company.
* Consolidated by the Company as a variable interest entity. See Note 3 — Significant accounting policies and Note 29 —Variable interest entities for further details.
The following table presents the wholly-owned subsidiaries of Curaleaf International Holings Limited ("Curaleaf International") as well as the entities in which Curaleaf International held a controlling financial interest as of December 31, 2025 and 2024:
As of December 31,
2025
2024
Entity name
Jurisdiction of Incorporation/Formation
Ownership %(1)
Curaleaf International Limited
UK
100%
100%
Four20 Pharma GmbH(2)
Germany
55%
55%
(1) Based on % of voting interests held by the Company.
(2) As of December 31, 2025 and 2024, the remaining 45% noncontrolling interest was held by the sellers of Four20 Pharma GmbH, which the Company acquired in September 2022. The remaining equity interest was acquired by the Company on April 30, 2026. See 'Non-controlling interests' herein and Note 18 — Redeemable non-controlling interest for further details.
The following table presents the wholly-owned subsidiaries of Curaleaf, Inc. as well as the entities in which Curaleaf, Inc., directly or indirectly, held a controlling financial interest as of December 31, 2025 and 2024:
As of December 31,
2025
2024
Entity name
Jurisdiction of Incorporation/Formation
Ownership %(1)
CLF AZ, Inc.
DE
100%
100%
CLF NY, Inc.
DE
100%
100%
Curaleaf CA, Inc.
DE
100%
100%
Curaleaf KY, Inc.
DE
100%
100%
Curaleaf Massachusetts, Inc.
MA
100%
100%
Curaleaf MD, LLC
MD
100%
100%
Curaleaf OGT, Inc.
DE
100%
100%
Curaleaf PA, LLC
DE
100%
100%
Focused Investment Partners, LLC
DE
100%
100%
CLF Maine, Inc.
DE
100%
100%
PalliaTech CT, Inc.
DE
100%
100%
PalliaTech Florida, Inc.
DE
100%
100%
PT Nevada, Inc.
DE
100%
100%
CLF Sapphire Holdings, Inc.
DE
100%
100%
Curaleaf NJ II, Inc.
DE
100%
100%
GR Companies, Inc.
DE
100%
100%
CLF MD Employer, LLC
MD
100%
100%
Curaleaf Columbia, LLC (formerly HMS Sales, LLC)
MD
100%
100%
MI Health, LLC
MD
100%
100%
Curaleaf Compassionate Care VA, LLC
VA
100%
100%
Curaleaf UT, LLC
DE
100%
100%
Curaleaf Processing, Inc
DE
100%
100%
Virginia's Kitchen, LLC
CO
100%
100%
Cura CO LLC
CO
100%
100%
Curaleaf DH, Inc.
DE
100%
100%
Curaleaf Stamford, Inc.
CT
100%
100%
CLF Holdings Alabama, Inc.
DE
100%
100%
IL Business Holding Corporation*
IL
Broad Horizon Holdings, LLC*
MA
CLF Oregon, LLC (formerly PalliaTech OR, LLC)(2)
DE
100%
Curaleaf Hemp, Inc.(2)
DE
100%
(1) Based on % of voting interests held by Curaleaf, Inc. with the exception of the entities which Curaleaf, Inc. consolidates as variable interest entities.
(2) Entity dissolved in 2025.
* Consolidated by Curaleaf, Inc. as a variable interest entity. See Note 3 — Significant accounting policies and Note 29 — Variable interest entities for further details.